Gout Flare Clinical Trial
Official title:
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
The purpose of this study is to evaluate whether immune cells and their subtypes in peripheral blood affects the asymptomatic hyperuricemia, gout flare, intercritical gout and advanced gout.
A number of studies have reported that innate immunity cells (such as blood monocytes and neutrophils) play a crucial role in the initiation and amplification of gout flare resulted from MSU deposition in the joint or tissue, leading to release NLRP3 inflammasome-mediated production of bioactive IL-1β. Further investigation demonstrated the role of blood neutrophils might contribute to the resolution of gout flare by forming aggregated neutrophil extracellular traps. Recently, a few in vitro experiments have indicated that adaptive immunity may be involved in mechanisms of gout. However, a global understanding of blood immune responses underlying gout is still unclear. Thus, we want to investigate the relationship between immune cells and their subtypes in peripheral blood and the gout. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03933007 -
Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare
|
Phase 4 | |
Not yet recruiting |
NCT04069325 -
Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy
|
N/A | |
Recruiting |
NCT05586958 -
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
|
Phase 3 | |
Active, not recruiting |
NCT06197828 -
Novel Biomarkers for Early Renal Injury in Children With Sepsis
|
||
Recruiting |
NCT05586971 -
Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
|
Phase 3 | |
Not yet recruiting |
NCT04849312 -
Prediction of 30-Day Readmission Using Machine Learning
|
||
Active, not recruiting |
NCT04784351 -
Prediction of Expected Length of Hospital Stay Using Machine Learning
|
||
Active, not recruiting |
NCT05045742 -
Prediction of Patient Deterioration Using Machine Learning
|
||
Completed |
NCT03203759 -
Hospital-Level Care at Home for Acutely Ill Adults
|
N/A | |
Recruiting |
NCT05936268 -
Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare
|
Phase 2 | |
Active, not recruiting |
NCT03621215 -
The Effect of Tart Cherry Juice on Risk of Gout Attacks
|
N/A | |
Recruiting |
NCT05658575 -
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
|
Phase 2/Phase 3 | |
Recruiting |
NCT03524222 -
Home Hospital for Suddenly Ill Adults
|
N/A | |
Not yet recruiting |
NCT06273813 -
Treatment of Topical Ketorolac Gel in Acute Gouty Flare
|
Phase 1 | |
Completed |
NCT04531280 -
Rural Home Hospital: Proof of Concept
|
N/A | |
Completed |
NCT05256303 -
Rural Hospital-Level Care at Home for Acutely Ill Adults
|
N/A | |
Not yet recruiting |
NCT06207045 -
The Effects of Limb Elevation During Gout Flare Episodes
|
N/A | |
Completed |
NCT04080570 -
Remote Physician Care for Home Hospital Patients
|
N/A |